clinical trial · NCT01385176
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
Heart FailureCongestive Heart FailureImplant of investigational device systemTitration during the randomization phaseTitration after the randomization phaseBlood Draw
brief summary
The NECTAR-HF feasibility trial is designed to evaluate the application of right vagal nerve stimulation in heart failure patients with a New York Heart Association Class III, an ejection fraction equal to or less than 35 %, and a narrow QRS duration equal to or less than 130 ms.
started
Sep 21, 2011
primary completion
May 1, 2014
completion
Jun 30, 2027
last updated
Sep 25, 2026
detailed description
The objectives of this study are to assess the impact of right vagal nerve stimulation on left ventricular remodeling, functional capacity, quality of life, and other measures in heart failure patients over a 6-month period. In addition, the study will assess the safety of the NECTAR-HF study system over an 18-month period.
official title
Neural Cardiac Therapy for Heart Failure Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol